SFX by Ex Libris Inc.

Title:	Characterization of sulfonylurea receptors in isolated human pancreatic islets
Source:	Journal of Cellular Biochemistry [0730-2312] Giannaccini, Gino yr:1998

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Boyd, A E E. "Characterization of the sulfonylurea receptor on beta cell membranes." The Journal of biological chemistry 263.6 (1988): 2589-92.
description	2.	Muta, T. "Effects of analogues and drugs on arginine vasopressin receptor binding in rat renal tubular basolateral membrane." さんぎょういかだいがくざっし 10.4 (1988): 391-.
description	3.	Billington, R. A., Travelli, C., Ercolano, E., Gal, R. "Characterization of NAD Uptake in Mammalian Cells." The Journal of biological chemistry 283.10 (2008): 6367-6374.
description	4.	Stephan, D. "Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular KATP channels." Diabetologia 49.9 (2006): 2039-2048.
description	5.	Tomanek, Robert J J. "Formation of the coronary vasculature during development." Angiogenesis 8.3 (2005): 273-84.
description	6.	Anderson, M E E. "Glutathione: an overview of biosynthesis and modulation." Chemico-biological interactions 112.com (1998): 1-14.
description	7.	Skillman, T G G. "The pharmacology of sulfonylureas." The American journal of medicine 70.2: 361-372.
description	8.	Shank, ANTHONY r. "Oral sulfonylureas for the treatment of type II diabetes: an update." Southern medical journal 79.3 (1986): 337-43.
description	9.	Lu, Shelly C. "Regulation of glutathione synthesis." Molecular aspects of medicine 30.1-2 (2008): 42-59.
description	10.	Browne, W. "Making molecular machines work." Nature nanotechnology 1.1 (2006): 25-35.
description	11.	Sunaga, Y. "The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: Comparison with the sulfonylureas and nateglinide." European Journal of Pharmacology 431.1 (2001): 119-125.
description	12.	Bruzzone, S. "Connexin 43 hemi channels mediate Ca2+regulated transmembrane NAD+ fluxes in intact cells." The FASEB journal 15.1 (2000): 10-12.
description	13.	Hambrock, A. "Effect of two amino acids in TM17 of sulfonylurea receptor SUR1 on the binding of ATP-sensitive K+ channel modulators." Diabetes 53.Suppl (2004).
description	14.	Hansten, P D D. "Chlorpropamide and chloramphenicol." Lancet, The 1.7650 (1970): 1173-1173.
description	15.	Ying, W. "NAD+ as a metabolic link between DNA damage and cell death." Journal of neuroscience research 79.1-2 (2005): 216-23.
description	16.	Melander, A. "Clinical pharmacology of glipizide." The American journal of medicine 75.5B (1983): 41-5.
description	17.	Genazzani, Richard A A. "NAD depletion by FK866 induces autophagy." Autophagy 4.3 (2007): 385-7.
description	18.	Bryan, J. "Insulin Secretagogues, Sulfonylurea Receptors and KATP Channels." Current pharmaceutical design 11.21 (2005): 2699-716.
description	19.	Gerthoffer, William T T. "Mechanisms of vascular smooth muscle cell migration." Circulation research 100.5 (2007): 607-21.
description	20.	Fishman, Glenn I I. "Understanding Conduction System Development: A Hop, Skip and Jump Away?" Circulation research 96.8 (2005): 809-811.